This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by August, G. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by August, G. P.
Related Collections
Right arrow Endocrinology

PEDIATRICS Vol. 102 No. 2 Supplement August 1998, pp. 517

Symposium on Controversies in the Diagnosis of Growth Hormone Deficiency

Gilbert P. August

From the Department of Endocrinology and Metabolism, Children's National Medical Center, and Department of Pediatrics, George Washington University, Washington, DC.

The first 20% of the full text of this article appears below.

    ARTICLE

There is unease among pediatric endocrinologists about the ability to correctly categorize short, poorly growing children. Are they growth hormone (GH)-deficient, partially deficient, or normal but short? To a great extent, this unease is illustrated by Dr Jennifer Bell's discussion of the inability of GH provocative test results to predict the response to GH treatment. Short children respond to GH treatment regardless of their results on GH provocative testing. Furthermore, it is recognized that GH provocative testing, the standard for diagnosing GH deficiency, is inexact. The results of GH provocative testing can vary . . . [Full Text of this Article]


This article has been cited by other articles:


Home page
 BMJHome page
J.-C. Carel, E. Ecosse, M. Nicolino, M. Tauber, J. Leger, S. Cabrol, I. Bastie-Sigeac, J.-L. Chaussain, and J. Coste
Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow up study of the French population based registry
BMJ, July 13, 2002; 325(7355): 70 - 70.
[Abstract] [Full Text] [PDF]